Answer
Brentuximab vedotin (Adcetris) should be used during pregnancy only if the benefit to the mother outweighs potential risks to the foetus, and a pregnant woman requiring treatment should be clearly advised of the potential foetal risk.
Sources for this answer
- Adcetris 50 mg powder for concentrate for solution for infusionTakeda UK Ltd · emc · SmPC §4.6 Fertility, pregnancy and lactation · Version 33Document updated
Sources checked